Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Biogen advances Alzheimer's drug to late-stage trial

Digest more
 · 13h · on MSN
Biogen moves Alzheimer’s drug to late-stage trials. Wall Street thinks it’s a mistake.
Biogen stock heads for its worst single-day drop since July 2024 on the heels of new clinical data.

Continue reading

 · 15h · on MSN
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
 · 20h
Biogen Advances Alzheimer’s Drug on Suggestion of Benefit
6h

The ADDF Highlights Encouraging Progress Toward Targeting Multiple Alzheimer's Pathologies in Biogen's Phase 2 Tau Study

Today, Biogen announced topline results from the Phase 2 CELIA study of diranersen, an investigational therapy designed to ...
2don MSN

Alzheimer’s drugs slammed as ‘ineffective’ in major review, but critics push back

Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...
1don MSN

Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India

Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
  • Privacy
  • Terms